Relay Therapeutics, Inc. (RLAY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/16/26
Relay Therapeutics, Inc. (RLAY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks TranscriptSeeking Alpha • 09/10/26
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in SeptemberGlobeNewsWire • 09/01/26
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes PharmaZacks Investment Research • 08/17/26
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/07/26
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate UpdatesGlobeNewsWire • 08/06/26
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026GlobeNewsWire • 07/30/26
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/30/26
Relay Therapeutics Insider Sale Tops $3 Million as Shares Surge 500% This Past YearThe Motley Fool • 06/29/26
Relay Therapeutics, Inc. (RLAY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/08/26
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in JuneGlobeNewsWire • 05/27/26
Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies TranscriptSeeking Alpha • 05/20/26
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular AnomaliesGlobeNewsWire • 05/19/26
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/05/26
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate UpdatesGlobeNewsWire • 05/05/26